Table 1.

Published peer-reviewed surgical triage schemas for urologic malignancies

Cancer Type/Stage	Goldman et al. [13]	Stensland et al. [8]	Kutikov et al. [9]	Desouky et al. [17]
Renal
cT1-2	• Can delay >12 weeks SRM • Delay 4–12 weeks if partial nephrectomy for mass >4 cm • Delay <4 weeks for radical nephrectomy	• Consider for delay based on patient considerations such as age, morbidity, symptoms, and tumor growth rate	• Can delay >3 mo for renal mass <3 cm • No delay for >T1b	• Delay T1 • No delay for T2
≥cT3	• No delay	• No delay	• No delay for >T1b	• No delay
Adrenal	• Delay <4 weeks if cancer is suspected or symptomatic • Delay >12 weeks if cancer is not suspected and asymptomatic	• Consider delay for less suspicious tumors (<6 cm, favorable imaging characteristics) • No delay for suspected ACC or tumors >6cm	N/A	N/A
UTUC	• No delay for nephroureterectomy	• No delay for high-grade and/or cT1+ tumors	• Delay >3 mo for low-grade UC • No delay for high-risk nonmuscle invasive or muscle-invasive UC	• Nephroureterectomy for high-risk last to be cancelled • Low-risk second cancellation tier
Bladder	• No delay for “high risk” • Delay 4–12 weeks for “not high risk”	• No delay for MIBC or CIS refractory to third-line therapy	• Delay >3 mo for low-grade UC • No delay for high-risk nonmuscle invasive or muscle-invasive UC	• Cystectomy for high-risk last to be cancelled • Cystectomy for low-risk—second cancellation tier
Prostate	• Delay <4 weeks if GG3-5 OR GG2 with more than 2 cores OR tumor length >5 mm OR Gleason 3_3 with >50% core positivity in number of cores OR any PSA >10 • Can delay >12 weeks if GG1 OR GG2 with 2 or fewer cores of max length <5 mm	• Consider radiation for NCCN high-risk patients • Surgery for select high-risk patients if ineligible for radiation	• Delay >3 mo for low- and intermediate risk • Delay <3 mo for high-risk	• Second cancellation tier
Testicular	• No delay for orchiectomy • Delay RPLND <4 weeks	• No delay for orchiectomy or postchemotherapy RPLND	N/A	• Orchiectomy last to be cancelled
Urethral/ Penile	• No delay for penile cancer	• Surgery for clinically invasive or obstructing cancers	N/A	N/A